These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 15093608)
1. Involvement of histone deacetylation in ras-induced down-regulation of the metastasis suppressor RECK. Chang HC; Liu LT; Hung WC Cell Signal; 2004 Jun; 16(6):675-9. PubMed ID: 15093608 [TBL] [Abstract][Full Text] [Related]
2. HER-2/neu represses the metastasis suppressor RECK via ERK and Sp transcription factors to promote cell invasion. Hsu MC; Chang HC; Hung WC J Biol Chem; 2006 Feb; 281(8):4718-25. PubMed ID: 16377629 [TBL] [Abstract][Full Text] [Related]
3. Silencing of transcription of the human luteinizing hormone receptor gene by histone deacetylase-mSin3A complex. Zhang Y; Dufau ML J Biol Chem; 2002 Sep; 277(36):33431-8. PubMed ID: 12091390 [TBL] [Abstract][Full Text] [Related]
4. Trichostatin A, a histone deacetylase inhibitor, activates the IGFBP-3 promoter by upregulating Sp1 activity in hepatoma cells: alteration of the Sp1/Sp3/HDAC1 multiprotein complex. Choi HS; Lee JH; Park JG; Lee YI Biochem Biophys Res Commun; 2002 Aug; 296(4):1005-12. PubMed ID: 12200149 [TBL] [Abstract][Full Text] [Related]
5. Downregulation of a tumor suppressor RECK by hypoxia through recruitment of HDAC1 and HIF-1alpha to reverse HRE site in the promoter. Lee KJ; Lee KY; Lee YM Biochim Biophys Acta; 2010 May; 1803(5):608-16. PubMed ID: 20080132 [TBL] [Abstract][Full Text] [Related]
6. Histone deacetylase inhibitor up-regulates RECK to inhibit MMP-2 activation and cancer cell invasion. Liu LT; Chang HC; Chiang LC; Hung WC Cancer Res; 2003 Jun; 63(12):3069-72. PubMed ID: 12810630 [TBL] [Abstract][Full Text] [Related]
7. Ras induces experimental lung metastasis through up-regulation of RbAp46 to suppress RECK promoter activity. Yeh HH; Tseng YF; Hsu YC; Lan SH; Wu SY; Raghavaraju G; Cheng DE; Lee YR; Chang TY; Chow NH; Hung WC; Liu HS BMC Cancer; 2015 Mar; 15():172. PubMed ID: 25885317 [TBL] [Abstract][Full Text] [Related]
8. Requirement of a specific Sp1 site for histone deacetylase-mediated repression of transforming growth factor beta Type II receptor expression in human pancreatic cancer cells. Zhao S; Venkatasubbarao K; Li S; Freeman JW Cancer Res; 2003 May; 63(10):2624-30. PubMed ID: 12750289 [TBL] [Abstract][Full Text] [Related]
9. Silencing of the metastasis suppressor RECK by RAS oncogene is mediated by DNA methyltransferase 3b-induced promoter methylation. Chang HC; Cho CY; Hung WC Cancer Res; 2006 Sep; 66(17):8413-20. PubMed ID: 16951151 [TBL] [Abstract][Full Text] [Related]
11. Transcriptional control of the RECK metastasis/angiogenesis suppressor gene. Sasahara RM; Brochado SM; Takahashi C; Oh J; Maria-Engler SS; Granjeiro JM; Noda M; Sogayar MC Cancer Detect Prev; 2002; 26(6):435-43. PubMed ID: 12507228 [TBL] [Abstract][Full Text] [Related]
12. RECK is a target of Epstein-Barr virus latent membrane protein 1. Liu LT; Peng JP; Chang HC; Hung WC Oncogene; 2003 Nov; 22(51):8263-70. PubMed ID: 14614450 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of histone deacetylase attenuates hypoxia-induced migration and invasion of cancer cells via the restoration of RECK expression. Jeon HW; Lee YM Mol Cancer Ther; 2010 May; 9(5):1361-70. PubMed ID: 20442303 [TBL] [Abstract][Full Text] [Related]
14. Essential role of mitogen-activated protein kinase pathway and c-Jun induction in epidermal growth factor-induced gene expression of human 12-lipoxygenase. Chen BK; Kung HC; Tsai TY; Chang WC Mol Pharmacol; 2000 Jan; 57(1):153-61. PubMed ID: 10617690 [TBL] [Abstract][Full Text] [Related]
15. Activation of the p21WAF1/CIP1 promoter independent of p53 by the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) through the Sp1 sites. Huang L; Sowa Y; Sakai T; Pardee AB Oncogene; 2000 Nov; 19(50):5712-9. PubMed ID: 11126357 [TBL] [Abstract][Full Text] [Related]
16. Attenuated expression and function of the RECK tumor suppressor under hypoxic conditions is mediated by the MAPK signaling pathways. Jeon HW; Lee KJ; Lee SH; Kim WH; Lee YM Arch Pharm Res; 2011 Jan; 34(1):137-45. PubMed ID: 21468925 [TBL] [Abstract][Full Text] [Related]
17. v-Src-mediated down-regulation of SSeCKS metastasis suppressor gene promoter by the recruitment of HDAC1 into a USF1-Sp1-Sp3 complex. Bu Y; Gelman IH J Biol Chem; 2007 Sep; 282(37):26725-26739. PubMed ID: 17626016 [TBL] [Abstract][Full Text] [Related]
18. Angiotensin II stimulates cardiac fibroblast migration via the differential regulation of matrixins and RECK. Siddesha JM; Valente AJ; Sakamuri SS; Yoshida T; Gardner JD; Somanna N; Takahashi C; Noda M; Chandrasekar B J Mol Cell Cardiol; 2013 Dec; 65():9-18. PubMed ID: 24095877 [TBL] [Abstract][Full Text] [Related]
19. The histone deacetylase inhibitor trichostatin A derepresses the telomerase reverse transcriptase (hTERT) gene in human cells. Hou M; Wang X; Popov N; Zhang A; Zhao X; Zhou R; Zetterberg A; Björkholm M; Henriksson M; Gruber A; Xu D Exp Cell Res; 2002 Mar; 274(1):25-34. PubMed ID: 11855854 [TBL] [Abstract][Full Text] [Related]
20. Histone deacetylase inhibitors activate INK4d gene through Sp1 site in its promoter. Yokota T; Matsuzaki Y; Miyazawa K; Zindy F; Roussel MF; Sakai T Oncogene; 2004 Jul; 23(31):5340-9. PubMed ID: 15107822 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]